View in EDS

POD-09.03: Endovesical epirubicin and interferon α 2b is comparable to BCG as adjuvant treatment for T1 tumours with or without CIS

Saved in:
Bibliographic Details
Title: POD-09.03: Endovesical epirubicin and interferon α 2b is comparable to BCG as adjuvant treatment for T1 tumours with or without CIS
Authors: Duchek, M.1, Wiklund, F.2, Jahnson, S.3, Mestad, O.4, Hellström, P.5, Hellsten, S.6, Malmström, P.U.7
Source: Urology. Sep2007 Supplement, Vol. 70 Issue 3, p28-28. 1p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first